4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-055599
Chief Financial Officer sold 29,166 shares at $54.04 ($1,576,131)
- Chief Financial Officer acquired 29,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-10-20 | Option exercise | +29,166 | $6.15 | $179,371 | 456,834 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-10-20 | Sale | −29,166 | $54.04 | $1,576,131 | 427,668 | D |
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-10-20 | Option exercise · Stock Option (right to buy) | −29,166 | 43,505 | D | ||
| Open-market sales · 29,166 sh · avg $54.04 · $1,576,131 | |||||||
Loading xslF345X03/doc4.xml…